On the other hand, inhibition of PRMT7 enhances RIG-I and MDA5 expression via reduction of H4R3me2s repressive histone mark at the promoters, which boosts the expression of downstream targets such as interferon-stimulated genes(ISGs) in melanoma, thus hampering tumor growth (22). Here, RIGI is linked to neoplasm.